130 related articles for article (PubMed ID: 35290470)
1. [Pathological processing in pancreatic ductal adenocarcinoma-What is new?].
Munding J; Tannapfel A
Chirurg; 2022 May; 93(5):453-460. PubMed ID: 35290470
[TBL] [Abstract][Full Text] [Related]
2. [Update of the S3 guidelines for pancreatic cancer. What is new for pathologists?].
Munding J; Lüttges J; Esposito I; Tannapfel A
Pathologe; 2014 Sep; 35(5):509-18; quiz 518-20. PubMed ID: 24981895
[TBL] [Abstract][Full Text] [Related]
3. Poorly differentiated resectable pancreatic cancer: is upfront resection worthwhile?
Crippa S; Partelli S; Zamboni G; Barugola G; Capelli P; Inama M; Bassi C; Pederzoli P; Falconi M
Surgery; 2012 Sep; 152(3 Suppl 1):S112-9. PubMed ID: 22766365
[TBL] [Abstract][Full Text] [Related]
4. ASO Author Reflections: Prognostic Index after Neoadjuvant Chemotherapy (PINC) in Pancreatic Ductal Adenocarcinoma as Novel Tumor Regression Grading System.
Redegalli M; Schiavo Lena M
Ann Surg Oncol; 2022 Jun; 29(6):3503. PubMed ID: 35187623
[No Abstract] [Full Text] [Related]
5. [New S3 guidelines on exocrine pancreatic cancer].
Tannapfel A;
Pathologe; 2012 Nov; 33 Suppl 2():266-8. PubMed ID: 23011018
[TBL] [Abstract][Full Text] [Related]
6. Prognosis of malignant intraductal papillary mucinous tumours of the pancreas after surgical resection. Comparison with pancreatic ductal adenocarcinoma.
Maire F; Hammel P; Terris B; Paye F; Scoazec JY; Cellier C; Barthet M; O'Toole D; Rufat P; Partensky C; Cuillerier E; Lévy P; Belghiti J; Ruszniewski P
Gut; 2002 Nov; 51(5):717-22. PubMed ID: 12377813
[TBL] [Abstract][Full Text] [Related]
7. [Ductal adenocarcinoma of the head of the pancreas: a critical study of R1 resection rates].
Delpero JR; Turrini O
Bull Cancer; 2008 Dec; 95(12):1193-8. PubMed ID: 19091653
[TBL] [Abstract][Full Text] [Related]
8. Role of the lymph node ratio in pancreatic ductal adenocarcinoma. Impact on patient stratification and prognosis.
La Torre M; Cavallini M; Ramacciato G; Cosenza G; Rossi Del Monte S; Nigri G; Ferri M; Mercantini P; Ziparo V
J Surg Oncol; 2011 Nov; 104(6):629-33. PubMed ID: 21713779
[TBL] [Abstract][Full Text] [Related]
9. Survival benefit of neoadjuvant therapy in patients with non-metastatic pancreatic ductal adenocarcinoma: A propensity matching and intention-to-treat analysis.
Sugimoto M; Takahashi N; Farnell MB; Smyrk TC; Truty MJ; Nagorney DM; Smoot RL; Chari ST; Carter RE; Kendrick ML
J Surg Oncol; 2019 Nov; 120(6):976-984. PubMed ID: 31452208
[TBL] [Abstract][Full Text] [Related]
10. Re-evaluation of classical prognostic factors in resectable ductal adenocarcinoma of the pancreas.
Åkerberg D; Ansari D; Andersson R
World J Gastroenterol; 2016 Jul; 22(28):6424-33. PubMed ID: 27605878
[TBL] [Abstract][Full Text] [Related]
11. [Pancreatic cancer. Molecular and surgical pathology].
Tannapfel A
Pathologe; 2010 Oct; 31 Suppl 2():225-8. PubMed ID: 20669020
[TBL] [Abstract][Full Text] [Related]
12. Pathology of pancreatic ductal adenocarcinoma: facts, challenges and future developments.
Esposito I; Konukiewitz B; Schlitter AM; Klöppel G
World J Gastroenterol; 2014 Oct; 20(38):13833-41. PubMed ID: 25320520
[TBL] [Abstract][Full Text] [Related]
13. DIPLOMA Approach for Standardized Pathology Assessment of Distal Pancreatectomy Specimens.
Lof S; Rajak R; Vissers FLIM; Korrel M; Bateman A; Verheij J; Verbeke C; Cataldo I; Besselink MG; Abu Hilal M
J Vis Exp; 2020 Feb; (156):. PubMed ID: 32065168
[TBL] [Abstract][Full Text] [Related]
14. Prognostic Factors of Survival After Neoadjuvant Treatment and Resection for Initially Unresectable Pancreatic Cancer.
Klaiber U; Schnaidt ES; Hinz U; Gaida MM; Heger U; Hank T; Strobel O; Neoptolemos JP; Mihaljevic AL; Büchler MW; Hackert T
Ann Surg; 2021 Jan; 273(1):154-162. PubMed ID: 30921051
[TBL] [Abstract][Full Text] [Related]
15. The impact of margin status determined by the one-millimeter rule on tumor recurrence and survival following pancreaticoduodenectomy for pancreatic ductal adenocarcinoma.
Nitta T; Nakamura T; Mitsuhashi T; Asano T; Okamura K; Tsuchikawa T; Tamoto E; Murakami S; Noji T; Kurashima Y; Ebihara Y; Nakanishi Y; Shichinohe T; Hirano S
Surg Today; 2017 Apr; 47(4):490-497. PubMed ID: 27677294
[TBL] [Abstract][Full Text] [Related]
16. Most pancreatic cancer resections are R1 resections.
Esposito I; Kleeff J; Bergmann F; Reiser C; Herpel E; Friess H; Schirmacher P; Büchler MW
Ann Surg Oncol; 2008 Jun; 15(6):1651-60. PubMed ID: 18351300
[TBL] [Abstract][Full Text] [Related]
17. Histopathological assessment of prognostic factors in pancreatic resection specimens using a standardised protocol.
Silvanto A; Balamurugan T; Bagwan IN
Pathologica; 2019 Mar; 111(1):24-30. PubMed ID: 31217619
[TBL] [Abstract][Full Text] [Related]
18. [Surgery for pancreatic cancer].
Welsch T; Büchler MW; Schmidt J
Z Gastroenterol; 2008 Dec; 46(12):1393-403. PubMed ID: 19053009
[TBL] [Abstract][Full Text] [Related]
19. [Surgical treatment of pancreatic cancer-What is new?].
Schmidt T; Belyaev O; Uhl W; Bruns CJ
Chirurg; 2022 May; 93(5):446-452. PubMed ID: 35357553
[TBL] [Abstract][Full Text] [Related]
20. Neoadjuvant Chemotherapy Enhances Local Postoperative Histopathological Tumour Stage in Borderline Resectable Pancreatic Cancer - A Matched-Pair Analysis.
Timmermann L; Rosumeck N; Klein F; Pratschke J; Pelzer U; Bahra M; Malinka T
Anticancer Res; 2019 Oct; 39(10):5781-5787. PubMed ID: 31570482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
